Work

Antibody-drug conjugates in NSCLC with actionable genomic alterations: Optimizing smart delivery of chemotherapy to the target

Year: 2025

Type: article

Source: Cancer Treatment Reviews

DOI: 10.1016/j.ctrv.2025.102902

Authors: Giannis Mountzios, Stephanie P.L. Saw, Lizza Hendriks, Jessica Menis, Tina Cascone, Oscar Arrieta, Jarushka Naidoo, Prodromos Koutoukoglou, Massimiliano Cani, Antoine Lefevre, Alfredo Addeo, Solange Peters, Jordi Remon

Institutions: Henry Dunant Hospital, SingHealth, SingHealth Duke-NUS Academic Medical Centre, Duke-NUS Medical School, National Cancer Centre Singapore, Maastricht University Medical Centre, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, The University of Texas MD Anderson Cancer Center, Instituto Nacional de Cancerología, Royal College of Surgeons in Ireland, Beaumont Hospital, Theageneio General Hospital, Institut Gustave Roussy, University Hospital of Geneva, Centre Hospitalier Universitaire Vaudois, University of Lausanne

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4407610743

FWCI: 8.827

Cites: 88

Cited by: 15

Related to: 10